Top

Published in:

Open Access 01-06-2009 | Review Paper

Molecular differentiation and specialization of vascular beds

Authors: Susana F. Rocha, Ralf H. Adams

Published in: Angiogenesis | Issue 2/2009

Abstract

Transport in the large and complex bodies of vertebrate organisms is mediated by extensive and highly branched tubular networks that are formed by endothelial cells. Blood vessels are responsible for systemic circulation, while the lymphatic vasculature drains extravasated plasma, proteins, particles, and cells from the interstitium. Endothelial cells of blood vessels and lymphatic vessels can be distinguished by the expression of certain molecular markers, which accompany or even contribute to functional and morphological differences. Even within the blood vessel network, some molecules and pathways selectively mark the endothelium of arteries, veins and capillaries and are thought to contribute to the differentiation of these vessels. Moreover, microvessels can acquire organ-specific specialization in response to local tissue-derived signals. This review summarizes molecular markers and pathways that are specifically expressed in the endothelium of certain vascular beds and vessel types. Special attention will be given to known functional roles in the morphogenesis of these vessels.

Wang HU et al (1998) Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93:741–753. doi:10.1016/S0092-8674(00)81436-1 PubMedCrossRef

Gerety SS et al (1999) Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell 4:403–414. doi:10.1016/S1097-2765(00)80342-1 PubMedCrossRef

Adams RH et al (1999) Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 13:295–306. doi:10.1101/gad.13.3.295 PubMedCrossRef

Bastide B et al (1993) Gap junction protein connexin40 is preferentially expressed in vascular endothelium and conductive bundles of rat myocardium and is increased under hypertensive conditions. Circ Res 73:1138–1149PubMed

Reed KE et al (1993) Molecular cloning and functional expression of human connexin37, an endothelial cell gap junction protein. J Clin Invest 91:997–1004. doi:10.1172/JCI116321 PubMedCrossRef

Bruzzone R et al (1993) Connexin40, a component of gap junctions in vascular endothelium, is restricted in its ability to interact with other connexins. Mol Biol Cell 4:7–20PubMed

Shutter JR et al (2000) Dll4, a novel Notch ligand expressed in arterial endothelium. Genes Dev 14:1313–1318PubMed

Mailhos C et al (2001) Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. Differentiation 69:135–144. doi:10.1046/j.1432-0436.2001.690207.x PubMedCrossRef

Claxton S, Fruttiger M (2004) Periodic Delta-like 4 expression in developing retinal arteries. Gene Expr Patterns 5:123–127. doi:10.1016/j.modgep.2004.05.004 PubMedCrossRef

10.

Herzog Y et al (2001) Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins. Mech Dev 109:115–119. doi:10.1016/S0925-4773(01)00518-4 PubMedCrossRef

11.

Lee P et al (2002) Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish. Proc Natl Acad Sci USA 99:10470–10475. doi:10.1073/pnas.162366299 PubMedCrossRef

12.

Martyn U, Schulte-Merker S (2004) Zebrafish neuropilins are differentially expressed and interact with vascular endothelial growth factor during embryonic vascular development. Dev Dyn 231:33–42. doi:10.1002/dvdy.20048 PubMedCrossRef

13.

Moyon D et al (2001) Plasticity of endothelial cells during arterial–venous differentiation in the avian embryo. Development 128:3359–3370PubMed

14.

Yuan L et al (2002) Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129:4797–4806PubMed

15.

Kaipainen A et al (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92:3566–3570. doi:10.1073/pnas.92.8.3566 PubMedCrossRef

16.

Tammela T et al (2008) Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454:656–660. doi:10.1038/nature07083 PubMedCrossRef

17.

Lawson ND et al (2001) Notch signaling is required for arterial–venous differentiation during embryonic vascular development. Development 128:3675–3683PubMed

18.

You LR et al (2005) Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 435:98–104. doi:10.1038/nature03511 PubMedCrossRef

19.

Saint-Geniez M et al (2003) The msr/apj gene encoding the apelin receptor is an early and specific marker of the venous phenotype in the retinal vasculature. Gene Expr Patterns 3:467–472. doi:10.1016/S1567-133X(03)00062-0 PubMedCrossRef

20.

Dekker RJ et al (2002) Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Kruppel-like factor (KLF2). Blood 100:1689–1698. doi:10.1182/blood-2002-01-0046 PubMedCrossRef

21.

Parmar KM et al (2006) Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J Clin Invest 116:49–58. doi:10.1172/JCI24787 PubMedCrossRef

22.

Huddleson JP et al (2004) Fluid shear stress induces endothelial KLF2 gene expression through a defined promoter region. Biol Chem 385:723–729. doi:10.1515/BC.2004.088 PubMedCrossRef

23.

Benjamin LE et al (1998) A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125:1591–1598PubMed

24.

le Noble F et al (2005) Control of arterial branching morphogenesis in embryogenesis: go with the flow. Cardiovasc Res 65:619–628. doi:10.1016/j.cardiores.2004.09.018 PubMedCrossRef

25.

le Noble F et al (2004) Flow regulates arterial–venous differentiation in the chick embryo yolk sac. Development 131:361–375. doi:10.1242/dev.00929 PubMedCrossRef

26.

Armulik A et al (2005) Endothelial/pericyte interactions. Circ Res 97:512–523. doi:10.1161/01.RES.0000182903.16652.d7 PubMedCrossRef

27.

Adams RH, Alitalo K (2007) Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 8:464–478. doi:10.1038/nrm2183 PubMedCrossRef

28.

Bergers G, Song S (2005) The role of pericytes in blood-vessel formation and maintenance. Neuro-oncol 7:452–464. doi:10.1215/S1152851705000232 PubMedCrossRef

29.

Houtchens GR et al (2008) Combined effects of microtopography and cyclic strain on vascular smooth muscle cell orientation. J Biomech 41:762–769. doi:10.1016/j.jbiomech.2007.11.027 PubMedCrossRef

30.

Kurpinski K et al (2006) Regulation of vascular smooth muscle cells and mesenchymal stem cells by mechanical strain. Mol Cell Biomech 3:21–34PubMed

31.

Liu SQ (1998) Influence of tensile strain on smooth muscle cell orientation in rat blood vessels. J Biomech Eng 120:313–320. doi:10.1115/1.2797996 PubMedCrossRef

32.

Abraham S et al (2008) Integrin beta1 subunit controls mural cell adhesion, spreading, and blood vessel wall stability. Circ Res 102:562–570. doi:10.1161/CIRCRESAHA.107.167908 PubMedCrossRef

33.

van Eys GJ et al (2007) Smoothelin in vascular smooth muscle cells. Trends Cardiovasc Med 17:26–30. doi:10.1016/j.tcm.2006.11.001 PubMedCrossRef

34.

Zanetti M et al (2004) EMILIN-1 deficiency induces elastogenesis and vascular cell defects. Mol Cell Biol 24:638–650. doi:10.1128/MCB.24.2.638-650.2004 PubMedCrossRef

35.

Patel A et al (2006) Elastin biosynthesis: The missing link in tissue-engineered blood vessels. Cardiovasc Res 71:40–49. doi:10.1016/j.cardiores.2006.02.021 PubMedCrossRef

36.

Karnik SK et al (2003) A critical role for elastin signaling in vascular morphogenesis and disease. Development 130:411–423. doi:10.1242/dev.00223 PubMedCrossRef

37.

Hellstrom M et al (2001) Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153:543–553. doi:10.1083/jcb.153.3.543 PubMedCrossRef

38.

Urness LD et al (2000) Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 26:328–331. doi:10.1038/81634 PubMedCrossRef

39.

Li DY et al (1999) Defective angiogenesis in mice lacking endoglin. Science 284:1534–1537. doi:10.1126/science.284.5419.1534 PubMedCrossRef

40.

Arthur HM et al (2000) Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol 217:42–53. doi:10.1006/dbio.1999.9534 PubMedCrossRef

41.

Oh SP et al (2000) Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci USA 97:2626–2631. doi:10.1073/pnas.97.6.2626 PubMedCrossRef

42.

Dickson MC et al (1995) Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121:1845–1854PubMed

43.

Davis S et al (1996) Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161–1169. doi:10.1016/S0092-8674(00)81812-7 PubMedCrossRef

44.

Sato TN et al (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70–74. doi:10.1038/376070a0 PubMedCrossRef

45.

Suri C et al (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171–1180. doi:10.1016/S0092-8674(00)81813-9 PubMedCrossRef

46.

Foo SS et al (2006) Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 124:161–173. doi:10.1016/j.cell.2005.10.034 PubMedCrossRef

47.

Korff T et al (2008) Role of ephrinB2 expression in endothelial cells during arteriogenesis: impact on smooth muscle cell migration and monocyte recruitment. Blood 112:73–81. doi:10.1182/blood-2007-12-128835 PubMedCrossRef

48.

Wu J et al (2008) KLF2 transcription factor modulates blood vessel maturation through smooth muscle cell migration. J Biol Chem 283:3942–3950. doi:10.1074/jbc.M707882200 PubMedCrossRef

49.

Olsson AK et al (2006) VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 7:359–371. doi:10.1038/nrm1911 PubMedCrossRef

50.

Shibuya M, Claesson-Welsh L (2006) Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 312:549–560. doi:10.1016/j.yexcr.2005.11.012 PubMedCrossRef

51.

Lawson ND et al (2002) Sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev Cell 3:127–136. doi:10.1016/S1534-5807(02)00198-3 PubMedCrossRef

52.

Hong CC et al (2006) Artery/vein specification is governed by opposing phosphatidylinositol-3 kinase and MAP kinase/ERK signaling. Curr Biol 16:1366–1372. doi:10.1016/j.cub.2006.05.046 PubMedCrossRef

53.

Jia H et al (2004) Vascular endothelial growth factor (VEGF)-D and VEGF-A differentially regulate KDR-mediated signaling and biological function in vascular endothelial cells. J Biol Chem 279:36148–36157. doi:10.1074/jbc.M401538200 PubMedCrossRef

54.

Makinen T et al (2001) Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J 20:4762–4773. doi:10.1093/emboj/20.17.4762 PubMedCrossRef

55.

Lawson ND et al (2003) Phospholipase C gamma-1 is required downstream of vascular endothelial growth factor during arterial development. Genes Dev 17:1346–1351. doi:10.1101/gad.1072203 PubMedCrossRef

56.

Covassin LD et al (2006) Distinct genetic interactions between multiple Vegf receptors are required for development of different blood vessel types in zebrafish. Proc Natl Acad Sci USA 103:6554–6559. doi:10.1073/pnas.0506886103 PubMedCrossRef

57.

Takahashi T et al (2001) A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J 20:2768–2778. doi:10.1093/emboj/20.11.2768 PubMedCrossRef

58.

Kawasaki T et al (1999) A requirement for neuropilin-1 in embryonic vessel formation. Development 126:4895–4902PubMed

59.

Mukouyama YS et al (2005) Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1-mediated positive feedback. Development 132:941–952. doi:10.1242/dev.01675 PubMedCrossRef

60.

Chen H et al (2000) Neuropilin-2 regulates the development of selective cranial and sensory nerves and hippocampal mossy fiber projections. Neuron 25:43–56. doi:10.1016/S0896-6273(00)80870-3 PubMedCrossRef

61.

Giger RJ et al (2000) Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins. Neuron 25:29–41. doi:10.1016/S0896-6273(00)80869-7 PubMedCrossRef

62.

Favier B et al (2006) Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Blood 108:1243–1250. doi:10.1182/blood-2005-11-4447 PubMedCrossRef

63.

Karpanen T et al (2006) Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J 20:1462–1472. doi:10.1096/fj.05-5646com PubMedCrossRef

64.

Caunt M et al (2008) Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell 13:331–342. doi:10.1016/j.ccr.2008.01.029 PubMedCrossRef

65.

Lai EC (2004) Notch signaling: control of cell communication and cell fate. Development 131:965–973. doi:10.1242/dev.01074 PubMedCrossRef

66.

Roca C, Adams RH (2007) Regulation of vascular morphogenesis by Notch signaling. Genes Dev 21:2511–2524. doi:10.1101/gad.1589207 PubMedCrossRef

67.

Krebs LT et al (2004) Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev 18:2469–2473. doi:10.1101/gad.1239204 PubMedCrossRef

68.

Krebs LT et al (2000) Notch signaling is essential for vascular morphogenesis in mice. Genes Dev 14:1343–1352PubMed

69.

Duarte A et al (2004) Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev 18:2474–2478. doi:10.1101/gad.1239004 PubMedCrossRef

70.

Gale NW et al (2004) Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci USA 101:15949–15954. doi:10.1073/pnas.0407290101 PubMedCrossRef

71.

Hellstrom M et al (2007) Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445:776–780. doi:10.1038/nature05571 PubMedCrossRef

72.

Siekmann AF et al (2008) Modulation of VEGF signalling output by the Notch pathway. Bioessays 30:303–313. doi:10.1002/bies.20736 PubMedCrossRef

73.

Leslie JD et al (2007) Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis. Development 134:839–844. doi:10.1242/dev.003244 PubMedCrossRef

74.

Suchting S et al (2007) The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci USA 104:3225–3230. doi:10.1073/pnas.0611177104 PubMedCrossRef

75.

Lobov IB et al (2007) Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci USA 104:3219–3224. doi:10.1073/pnas.0611206104 PubMedCrossRef

76.

Liu ZJ et al (2003) Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol 23:14–25. doi:10.1128/MCB.23.1.14-25.2003 PubMedCrossRef

77.

Seo S et al (2006) The forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development. Dev Biol 294:458–470. doi:10.1016/j.ydbio.2006.03.035 PubMedCrossRef

78.

Hayashi H, Kume T (2008) Foxc transcription factors directly regulate Dll4 and Hey2 expression by interacting with the VEGF-Notch signaling pathways in endothelial cells. PLoS One 3:e2401. doi:10.1371/journal.pone.0002401 PubMedCrossRef

79.

Ioannidou S et al (2006) An in vitro assay reveals a role for the diaphragm protein PV-1 in endothelial fenestra morphogenesis. Proc Natl Acad Sci USA 103:16770–16775. doi:10.1073/pnas.0603501103 PubMedCrossRef

80.

Stan RV et al (2004) PV1 is a key structural component for the formation of the stomatal and fenestral diaphragms. Mol Biol Cell 15:3615–3630. doi:10.1091/mbc.E03-08-0593 PubMedCrossRef

81.

Stan RV et al (1999) PV-1 is a component of the fenestral and stomatal diaphragms in fenestrated endothelia. Proc Natl Acad Sci USA 96:13203–13207. doi:10.1073/pnas.96.23.13203 PubMedCrossRef

82.

Hnasko R et al (2002) Distribution and characterization of plasmalemma vesicle protein-1 in rat endocrine glands. J Endocrinol 175:649–661. doi:10.1677/joe.0.1750649 PubMedCrossRef

83.

Roberts WG, Palade GE (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108(Pt 6):2369–2379PubMed

84.

Esser S et al (1998) Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 140:947–959. doi:10.1083/jcb.140.4.947 PubMedCrossRef

85.

Cao R et al (2004) Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res 94:664–670. doi:10.1161/01.RES.0000118600.91698.BB PubMedCrossRef

86.

LeCouter J et al (2001) Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412:877–884. doi:10.1038/35091000 PubMedCrossRef

87.

Carpenter B et al (2005) VEGF is crucial for the hepatic vascular development required for lipoprotein uptake. Development 132:3293–3303. doi:10.1242/dev.01902 PubMedCrossRef

88.

Lammert E et al (2003) Role of VEGF-A in vascularization of pancreatic islets. Curr Biol 13:1070–1074. doi:10.1016/S0960-9822(03)00378-6 PubMedCrossRef

89.

Inai T et al (2004) Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol 165:35–52PubMed

90.

Kamba T et al (2006) VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 290:H560–H576. doi:10.1152/ajpheart.00133.2005 PubMedCrossRef

91.

Wallow IH, Geldner PS (1980) Endothelial fenestrae in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 19:1176–1183PubMed

92.

Schlageter KE et al (1999) Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties. Microvasc Res 58:312–328. doi:10.1006/mvre.1999.2188 PubMedCrossRef

93.

Roberts WG et al (1998) Host microvasculature influence on tumor vascular morphology and endothelial gene expression. Am J Pathol 153:1239–1248PubMed

94.

Engelhardt B (2003) Development of the blood–brain barrier. Cell Tissue Res 314:119–129. doi:10.1007/s00441-003-0751-z PubMedCrossRef

95.

Liebner S et al (2008) Wnt/beta-catenin signaling controls development of the blood–brain barrier. J Cell Biol 183:409–417. doi:10.1083/jcb.200806024 PubMedCrossRef

96.

Stenman JM et al (2008) Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science 322:1247–1250. doi:10.1126/science.1164594 PubMedCrossRef

97.

Srinivasan RS et al (2007) Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. Genes Dev 21:2422–2432. doi:10.1101/gad.1588407 PubMedCrossRef

98.

Hong YK et al (2002) Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn 225:351–357. doi:10.1002/dvdy.10163 PubMedCrossRef

99.

Petrova TV et al (2002) Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J 21:4593–4599. doi:10.1093/emboj/cdf470 PubMedCrossRef

100.

Wigle JT et al (2002) An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 21:1505–1513. doi:10.1093/emboj/21.7.1505 PubMedCrossRef

101.

Johnson NC et al (2008) Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity. Genes Dev 22:3282–3291. doi:10.1101/gad.1727208 PubMedCrossRef

102.

Breiteneder-Geleff S et al (1999) Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154:385–394PubMed

103.

Hong YK et al (2004) Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet 36:683–685. doi:10.1038/ng1383 PubMedCrossRef

104.

Alitalo K et al (2005) Lymphangiogenesis in development and human disease. Nature 438:946–953. doi:10.1038/nature04480 PubMedCrossRef

105.

Francois M et al (2008) Sox18 induces development of the lymphatic vasculature in mice. Nature 456:643–647. doi:10.1038/nature07391 PubMedCrossRef

106.

Irrthum A et al (2003) Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am J Hum Genet 72:1470–1478. doi:10.1086/375614 PubMedCrossRef

Title: Molecular differentiation and specialization of vascular beds
Authors: Susana F. Rocha
Ralf H. Adams
Publication date: 01-06-2009
Publisher: Springer Netherlands
Published in: Angiogenesis / Issue 2/2009
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI: https://doi.org/10.1007/s10456-009-9132-x

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Molecular differentiation and specialization of vascular beds

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2009

Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature

Morphological and molecular aspects of physiological vascular morphogenesis

Fibronectins in vascular morphogenesis

Intussusceptive angiogenesis and its role in vascular morphogenesis, patterning, and remodeling

Semaphorins and tumor angiogenesis

Semaphorins and tumor angiogenesis

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page